Skip to content
Argos

Participation minoritaire de Ageas dans AG Insurance (2026) [2]

AcquisitionCompletedAssurance (vie)Belgique28 Apr 2026

Buyer

Ageas

Belgique

Target

AG Insurance

Belgique

Deal value

7.6 bn EUR

announced enterprise value

Deal value
7.6 bn EUR
Stake acquired
25%

Parties

Buyer

Ageas

Belgique

Target

AG Insurance

Belgique

Seller

BNP Paribas Fortis

The target

AG Insurance est un assureur belge, partenaire de bancassurance de BNP Paribas Fortis. La société propose une gamme complète de services incluant l'épargne, la protection et l'assurance dommages.

Elle joue un rôle dans le secteur financier belge en offrant des solutions d'assurance aux particuliers et aux entreprises. Son activité est étroitement liée à son partenariat de long terme avec le réseau bancaire.

Text based on: article source

Broad sector
Services financiers
Buyer sub-sector
Assurance et courtier généraliste - Autres
Buyer business
Groupe d'assurance international
Seller sub-sector
Banques commerciales
Seller business
Banque

Timeline

Announced
28 Apr 2026
Status
Completed

Structure

Deal type
Acquisition
Stake acquired
25%

Detailed valuation, justified multiples, sources and strategic rationale

Sign in to continue

The free Discovery account includes 150 credits a month and 50 UCP a week for Le Paon.

Create an account

Other deals in Assurance (vie)

15 Feb 2024

Completed

Unipol Gruppo S.p.A.

Italie

UnipolSai Assicurazioni

Italie

Assurance (vie)Acquisition
Deal value
7.64 bn EUR
Stake
14.8%

1 Apr 2021

Completed

Brookfield Business Partners L.P.

Bermudes

Sagen

Canada

Assurance (vie)Buyout and take-private
Deal value
2.56 bn EUR
Stake
43%

1 Oct 2023

Completed

V-Sciences Investments Pte Ltd (Temasek Holdings)

Singapour

Niva Bupa Health Insurance Company Limited

Inde

Assurance (vie)Acquisition
Deal value
1.53 bn EUR
Stake
5.9%
See the dealSeller: True North (FKA India Value Fund Advisors)

Source: party press releases, reference documents and deal notices. Verify with the parties for any critical use.